Want to see MLTX full AI Analyst Report?
MLTX Analyst Ratings
Strong Buy
8 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
MLTX Stock 12 Month Forecast
Average Price Target
$33.00
▲(112.08% Upside)
| Highest Price Target$50.00 | Average Price Target$33.00 | Lowest Price Target$17.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
RBC Capital
$17
Hold
9.25%
Upside
Reiterated
10/16/26
H.C. Wainwright
$50
Buy
221.34%
Upside
Reiterated
10/05/26
Wedbush
$34
Buy
118.51%
Upside
Reiterated
10/05/26
Leerink Partners
$30
Buy
92.80%
Upside
Reiterated
10/01/26
TD Cowen
―
Buy
―
Reiterated
10/01/26
LifeSci Capital
$33
Buy
112.08%
Upside
Reiterated
09/30/26
BTIG
$30
Buy
92.80%
Upside
Reiterated
08/10/26
Needham
$30
Buy
92.80%
Upside
Reiterated
08/10/26
Clear Street
$70
Buy
349.87%
Upside
Reiterated
06/22/26
Goldman Sachs
$11→$12
Sell
-22.88%
Downside
Reiterated
05/11/26
Wolfe Research
$12→$24
Buy
54.24%
Upside
Upgraded
03/23/26
Citi
$6
Sell
-61.44%
Downside
Reiterated
03/20/26
Rothschild & Co Redburn
$12→$40
Buy
157.07%
Upside
Upgraded
03/19/26
Stifel Nicolaus
$13→$19
Hold
22.11%
Upside
Reiterated
03/01/26
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
RBC Capital
$17
Hold
9.25%
Upside
Reiterated
10/16/26
H.C. Wainwright
$50
Buy
221.34%
Upside
Reiterated
10/05/26
Wedbush
$34
Buy
118.51%
Upside
Reiterated
10/05/26
Leerink Partners
$30
Buy
92.80%
Upside
Reiterated
10/01/26
TD Cowen
―
Buy
―
Reiterated
10/01/26
LifeSci Capital
$33
Buy
112.08%
Upside
Reiterated
09/30/26
BTIG
$30
Buy
92.80%
Upside
Reiterated
08/10/26
Needham
$30
Buy
92.80%
Upside
Reiterated
08/10/26
Clear Street
$70
Buy
349.87%
Upside
Reiterated
06/22/26
Goldman Sachs
$11→$12
Sell
-22.88%
Downside
Reiterated
05/11/26
Wolfe Research
$12→$24
Buy
54.24%
Upside
Upgraded
03/23/26
Citi
$6
Sell
-61.44%
Downside
Reiterated
03/20/26
Rothschild & Co Redburn
$12→$40
Buy
157.07%
Upside
Upgraded
03/19/26
Stifel Nicolaus
$13→$19
Hold
22.11%
Upside
Reiterated
03/01/26
Best Analysts Covering MoonLake Immunotherapeutics
3 Months
Success Rate
17/27 ratings generated profit
Average Return
+27.89%
Copying Thomas Smith's trades and holding each position for 3 Months would result in 62.96% of your transactions generating a profit, with an average return of +27.89% per trade.
1 Year
Success Rate
13/27 ratings generated profit
Average Return
+59.55%
Copying Thomas Smith's trades and holding each position for 1 Year would result in 48.15% of your transactions generating a profit, with an average return of +59.55% per trade.
2 Years
Success Rate
9/27 ratings generated profit
Average Return
+32.54%
Copying Thomas Smith's trades and holding each position for 2 Years would result in 33.33% of your transactions generating a profit, with an average return of +32.54% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
MLTX Analyst Recommendation Trends
Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
18
17
15
8
10
Buy
5
4
4
1
2
Hold
2
2
1
1
2
Sell
1
1
0
0
0
Strong Sell
0
0
0
0
0
total
26
24
20
10
14
Each month's total comprises the sum of three months' worth of ratings.
MLTX Financial Forecast
MLTX Stock Forecast FAQ
What is MLTX’s average 12-month price target, according to analysts?
Based on analyst ratings, MoonLake Immunotherapeutics’s 12-month average price target is 33.00.
What is MLTX’s upside potential, based on the analysts’ average price target?
MoonLake Immunotherapeutics has 112.08% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is MLTX a Buy, Sell or Hold?
MoonLake Immunotherapeutics has a consensus rating of Strong Buy which is based on 8 buy ratings, 1 hold ratings and 0 sell ratings.
What is MoonLake Immunotherapeutics’s price target?
The average price target for MoonLake Immunotherapeutics is 33.00. This is based on 9 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $50.00 ,the lowest forecast is $17.00. The average price target represents 112.08% Increase from the current price of $15.56.
The highest analyst price target is $50.00 ,the lowest forecast is $17.00. The average price target represents 112.08% Increase from the current price of $15.56.
What do analysts say about MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics’s analyst rating consensus is a Strong Buy. This is based on the ratings of 9 Wall Streets Analysts.
How can I buy shares of MLTX?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.